Trial Outcomes & Findings for Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients (NCT NCT01127737)

NCT ID: NCT01127737

Last Updated: 2015-04-03

Results Overview

The number of control and intervention participants who checked their skin for cancer within the 1 month after the study visit.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

75 participants

Primary outcome timeframe

1 month

Results posted on

2015-04-03

Participant Flow

Subjects were recruited from Northwestern University's kidney transplant recipient population. Participants were returning for routine care to their nephrologists 1 to 1.2 years or 3 to 7 years after transplantation.

Participant milestones

Participant milestones
Measure
Control
Control group received only intiial assessment at the time of physician visit and education as usually provided during the physician visit.
Intervention
Educational intervention consisting of a mnemonic and a workbook used by kidney transplant recipients (KTRs) to assist with early detection of SCCs.
Overall Study
STARTED
37
38
Overall Study
COMPLETED
37
38
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=37 Participants
Control group received only intiial assessment at the time of physician visit and education as usually provided during the physician visit.
Intervention
n=38 Participants
Educational intervention consisting of a mnemonic and a workbook used by kidney transplant recipients (KTRs) to assist with early detection of SCCs.
Total
n=75 Participants
Total of all reporting groups
Age, Continuous
58 years
n=5 Participants
61 years
n=7 Participants
60 years
n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
17 Participants
n=7 Participants
32 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
21 Participants
n=7 Participants
43 Participants
n=5 Participants
Region of Enrollment
United States
37 participants
n=5 Participants
38 participants
n=7 Participants
75 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 month

Population: Per protocol

The number of control and intervention participants who checked their skin for cancer within the 1 month after the study visit.

Outcome measures

Outcome measures
Measure
Intervention
n=38 Participants
Educational intervention consisting of a mnemonic and a workboook
Placebo
n=37 Participants
Number of Control and Intervention Participants on Skin Self-examination Performance at Follow-up 1 Month After Intervention
34 Participants
8 Participants

Adverse Events

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

June Robinson, MD

Northwestern University

Phone: 312-695-6624

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place